- Report
- May 2025
- 200 Pages
Global
From €2210EUR$2,490USD£1,909GBP
- Report
- May 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- August 2025
- 401 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- January 2025
- 182 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- November 2024
- 180 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- June 2025
- 400 Pages
Global
From €4392EUR$4,949USD£3,795GBP
- Report
- August 2024
- 141 Pages
Global
From €2662EUR$2,999USD£2,300GBP
- Report
- June 2024
- 209 Pages
Global
From €3772EUR$4,250USD£3,259GBP
- Report
- June 2025
- 200 Pages
Japan
From €2210EUR$2,490USD£1,909GBP
- Report
- August 2022
- 115 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- October 2023
- 145 Pages
Global
From €2796EUR$3,150USD£2,415GBP
- Book
- September 2010
- 544 Pages
- Book
- May 2022
- 1040 Pages
- Book
- May 2022
- 3296 Pages
- Book
- May 2022
- 1040 Pages
- Book
- April 2019
- 816 Pages
- Book
- September 2016
- 680 Pages
Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) that affects the large intestine. It is characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms of UC include abdominal pain, bloody diarrhea, fatigue, and weight loss. Treatment options for UC include medications, lifestyle changes, and surgery.
The UC market is a subset of the larger Gastroenterology market. It is a growing market, driven by an increasing prevalence of IBD and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for UC.
Some of the companies in the UC market include AbbVie, Allergan, AstraZeneca, Janssen, Pfizer, and Takeda. Show Less Read more
